Digital Content 
NEWS #PharmaBuzz
18 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/elancos-credelio-quattro-ca1-lotilaner-moxidectin-praziquantel-and-pyrantel-chewable-tablets-receives-first-fda-conditional-approval-for-treatment-of-new-world-screwworm-in-dogs-302645913.html
22 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/22/3065511/0/en/Tarsus-to-Present-Several-Scientific-Abstracts-Highlighting-the-Global-Prevalence-of-Demodex-Blepharitis-and-the-Clinical-Impact-of-XDEMVY-at-the-American-Society-of-Cataract-and-R.html
23 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/now-available-credelio-quattro-lotilaner-moxidectin-praziquantel-and-pyrantel-chewable-tablets-provides-broadesti-parasite-protection-of-its-kind-302357947.html
17 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/17/2964866/0/en/Tarsus-Launches-Your-Mitey-Problem-the-First-Direct-to-Consumer-TV-Campaign-for-XDEMVY-lotilaner-ophthalmic-solution-0-25.html
07 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/elanco-receives-fda-approval-for-credelio-quattro-lotilaner-moxidectin-praziquantel-and-pyrantel-chewable-tablets-the-broadesti-canine-oral-parasiticide-protection-in-a-single-monthly-dose-302269212.html
25 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/25/2953387/0/en/Tarsus-to-Participate-in-Fireside-Chat-at-UBS-Virtual-Ophthalmology-Day-2024.html
Share